Last week I discussed at some length with curie.md’s Andrew Yukawa the White House’s May 12 drug pricing executive order and what it says about the US healthcare market more generally, the federal government’s role, healthcare efficiency and effectiveness, care quality the industry’s success and its future.
The interview is at: